Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

PaperCitations, authors & open-access status

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 65 citations, 2018 year and closed oa status.

65
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Laia Curto‐Barredo
Author
British Journal of Dermatology
Journal
Urticaria and Related Conditions
Topic
Urticaria and Related Conditions
Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Topic
Autoimmune Bullous Skin Diseases
Topic
470M+ articles · free account